Pall creates Pall Biotech
Company Announcements Axsun Technologies opened a direct office in the UK in 2006. Endress+Hauser opened a new production site in Suzhou, China to manufacture level, pressure, temperature and analytical measuring devices. Three production centers will move to the 7,850 sq. meter building. Bay-Tec Engineering licensed Finesse’s TruBio Bioreactor Control Operating System. Sionex named Eric Kirleis […]
There were a number of changes to this month’s IBO stock table. A new stock index was created, the Diversified Instrumentation Stock Index, which consists of six large companies (Agilent Technologies, AMETEK, Danaher, Mettler-Toledo International, Roper Industries and Teledyne Technologies) that manufacture a wide variety of products, including analytical and life science instruments. Other changes […]
Sunnyvale, CA and Toronto, Canada 1/29/07—MDS has signed a definitive agreement to purchase Molecular Devices for $615 million in cash, or $35.50 per share, a 49% premium over the January 26 trading price. In the first 12 months, the acquisition is expected to add $190 million in revenues and $45–$50 million in EBITDA (earnings before […]
The proposed acquisition of Molecular Devices by MDS Sciex (see page 2) will create a company with an estimated $470 million in fiscal 2006 revenues, putting it among the top 20 companies in the analytical and life science instrument industry (see IBO 4/15/06). In essence, the purchase transforms MDS Sciex into a full-blown instrument company, […]
Upland, CA 1/11/07—UVP, a suppler of laboratory imaging systems, was acquired by private equity investment firm Carlisle Enterprises on January 2. “Carlisle’s access to capital markets, their industry knowledge and their operating expertise represent significant support for UVP’s continued growth and development,” stated Leighton Smith, president and CEO of UVP. Carlisle’s previous laboratory-related investments include […]
Palm Springs, California’s desert air and sunny days were once again a perfect background for the Association for Laboratory Automation’s (ALA) annual LabAutomation conference. Held January 28–31 and accompanied by a three-day exhibition, the conference drew 4,600 registrants, a 9% increase from last year (see IBO 1/31/06). However, the number of exhibitors fell 15% to […]
Earlier this month, the FDA gave its recommendations to Congress for the next reauthorization of the Prescription Drug User Fee program. In order to support these changes, the FDA recommends that the annual user fee collections be increased $87.4 million to $392.8 million. The Prescription Drug User Fee Act (PDUFA) of November 1992 first authorized […]
The editors of R&D Magazine and analysts from Batelle expect that total R&D spending in the US will rise 2.85% to $338.3 billion in 2007. Industry spending is forecast to account for $243.9 billion, a 3.30% increase from 2006, and academia is predicted to do $52.2 billion worth of work on R&D, a 1.83% increase. […]
College, Station, TX 1/22/07—OI Corporation CEO, President and Chairman William W. Botts has been placed on paid administrative leave effective January 21 as the board of directors conducts a voluntary internal review of stock option grants and exercises, and related compensation procedures and accounting matters. Vice President, General Manager and board member Richard W.K. Chapman […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
